Metabolite tells cells whether to repair DNA

Researchers have figured out how a specific metabolite controls the activity of DNA repair and how sensitive tissues are to cancer treatment

2023-11-02

(Press-News.org) Metabolites called nucleotides are the building blocks of DNA and can impact cancer’s sensitivity or resistance to chemotherapy and radiation in brain cancer.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way.

“We learned that if you increase a cell’s GTP levels, it makes it really resistant to radiation or chemotherapy. Lowering GTP levels, the cell becomes much more sensitive,” said Daniel Wahl, M.D., Ph.D., associate professor of radiation oncology at Michigan Medicine and senior author of this paper.

Researchers have long known that levels of nucleotides like GTP control how fast DNA damage is repaired, which in turn controls sensitivity to therapies.

Researchers previously thought that this only happened because nucleotides are the building blocks that form DNA. But these findings uncover an entirely new way that nucleotides control DNA repair.

“GTP impacts resistance or sensitivity to treatment not just because it’s a building block of DNA, as we previously thought,” Wahl continued.

“Instead of only affecting the physical structure of the DNA, it also acts as a signaler. The levels of GTP turn on a signaling pathway and give cells instructions to repair damaged DNA.”

What’s more, Wahl and collaborator Weihua Zhou, Ph.D., found this to be true for normal tissue in addition to cancer cells.

“It’s a generalizable finding,” said Zhou, research assistant professor of radiation oncology and first author of the study.

“In the future, we’d like to develop therapeutics that leverage the relationship between GTP and DNA damage response, both to make cancer cells more sensitive to chemotherapy and radiation and also to boost GTP levels to protect normal tissue from damage.”

Wahl and a team of researchers have an ongoing clinical trial for patients with brain cancer focused on the role of GTP in treatment responses.

Wahl says these findings are fundamental biologic discovery that translates into clinical applications for this trial and potential future trials.

“We knew that depleting GTP might make brain cancers respond better to chemotherapy and radiation. Now these findings show why that's happening,” Wahl said.

The discovery that GTP acts as a signaler helps explain the biological underpinnings of why focusing on GTP is a worthwhile pursuit and could help researchers figure out which patients will derive the most benefit from GTP modulators in the clinical trial.

“When the signaling pathway is active, the cancer is resistant to radiation and chemotherapy,” Wahl continued. “These findings might help us select the right patients for the next line of clinical trials.

Additional authors: Zitong Zhao, Angelica Lin, John Z Yang, Jie Xu, Kari Wilder-Romans, Annabel Yang, Jing Li, Sumeet Solanki, Jennifer M Speth, Natalie Walker, Andrew J Scott, Lu Wang, Bo Wen, Anthony Andren, Li Zhang, Ayesha U Kothari, Yangyang Yao, Erik R Peterson, Navyateja Korimerla, Christian K Werner, Alexander Ullrich, Jessica Liang, Janna Jacobson, Sravya Palavalasa, Alexandra M O’Brien, Ameer L Elaimy, Sean P Ferris, Shuang G Zha, Jann N Sarkari, Balázs Győrffy, Shuqun Zhang, Wajd N Al-Holou, Yoshie Umemura, Meredith A Morgan, Theodore S Lawrence, Costas A Lyssioti, Marc Peters-Golden5, Yatrik M Shah

Funding: Forbes Institute for Cancer Discovery; NCI (R37CA258346, K08CA234416, F32CA260735, R01CA240515. R37CA237421, R01CA248160, R01CA244931, R35HL144979, R01CA148828, R01CA245546, and R01DK095201); NINDS (R01NS129123); Damon Runyon Cancer Foundation; the Sontag Foundation; the Ivy Glioblastoma Foundation; Alex’s Lemonade Stand Foundation; the Chad Tough Defeat DIPG foundation. Emerging Scholars program of the Taubman Institute via a gift from William Parfet; University of Michigan Medical School Pandemic Research Recovery grant (U083054); Crohn’s and Colitis Foundation Research fellow award (623914); DP2 OD030734; National Research, Development and Innovation Office (RRF-2.3.1-21-2022-00015, TKP2021-NVA-15); UMCCC Core Grant (P30CA046592); NIH (R35HL144979). and UMCCC Core Grant (P30CA046592).

Disclosures: D.R.W has received consulting fees from Agios Pharmaceuticals and Innocrin Pharmaceuticals and is an inventor on patents pertaining to the treatment of patients with brain tumors (U.S. Provisional Patent Application 63/416,146, U.S. Provisional Patent Application 62/744,342, U.S. Provisional Patent Applicant 62/724,337). S.G.Z reports unrelated patents licensed to Veracyte, and that a family member is an employee of Artera and holds stock in Exact Sciences. M.A.M gets research support and honoraria from AstraZeneca. No disclosures were reported by the other authors.

Paper cited: “GTP signaling links metabolism, DNA repair, and responses to genotoxic stress,” Cancer Discovery. DOI: 10.1158/2159-8290.CD-23-0437/729826

END

ELSE PRESS RELEASES FROM THIS DATE:

American Thyroid Association® names Trevor E. Angell, MD new Editor-in-Chief of Clinical Thyroidology®

2023-11-02

The American Thyroid Association® (ATA®) is pleased to announce that Trevor E. Angell, MD has been selected as the new Editor-in-Chief of the ATA monthly journal Clinical Thyroidology®. Dr. Angell’s term as Editor-in-Chief will begin in January 2024. Clinical Thyroidology is one of the ATA’s official journals and is published in partnership with Mary Ann Liebert, Inc. This highly valued abstract and commentary publication provides a comprehensive look at clinical thyroid literature. Experts ...

Hollings researchers uncover new targets for breast cancers resistant to standard therapies

2023-11-02

Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the U.S. Food and Drug Administration or currently in clinical trials could be repurposed for certain breast cancer patients whose cancer has become resistant to standard therapies. Ozgur Sahin, Ph.D., a professor and SmartState Endowed Chair in the Department of Biochemistry and Molecular Biology, led the research, which was published Nov. 2 in Nature Communications. The research, funded by an American Cancer Society Research Scholar Grant, started as an investigation into cancer resistance to the drug tamoxifen but expanded as the research questions led down new ...

Start-up dedicated to developing new antibiotics

2023-11-02

It all began with basic research: While conducting laboratory experiments, a team at the Technical University of Munich (TUM) came across an active agent against multidrug-resistant bacteria with a fundamental difference to antibiotics developed to date. The researchers have since established a start-up to develop a new drug based on this agent. The entrepreneurs have now been nominated for Science Breakthrough of the Year in the Science Start-Up category at the international Falling Walls summit. Rising numbers of bacteria are developing ...

Two million European households could abandon the electrical grid by 2050

2023-11-02

Researchers report that 53% of European freestanding homes could have supplied all their own energy needs in 2020 using only local rooftop solar radiation, and this technical feasibility could increase to 75% in 2050. Publishing November 2 in the journal Joule, the study shows that there is no economic advantage for individual households to be fully self-sufficient under current or future conditions, though in some cases the costs are on par with remaining on-grid. The researchers estimate that self-sufficiency will be economically feasible for 5% (two million) of Europe’s 41 million freestanding single-family homes in 2050, ...

One sleepless night can rapidly reverse depression for several days

2023-11-02

All-nighters can cause giddy and slap-happy feelings This effect is caused by increased dopamine release in distributed brain regions This dopamine signal also enhances plasticity in the neuronal connections, causing a potent antidepressant effect that lasts for days Study suggests that prefrontal cortex and its dopamine inputs are key for rapid plasticity and antidepressant effects after brief sleep loss EVANSTON, Ill. — Most people who have pulled an all-nighter are all too familiar with that “tired and wired” ...

Circuit-specific gene therapy brings new hope for treatment of Parkinson’s disease

2023-11-02

Researchers from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) and their collaborators have developed a gene therapy strategy to selectively manipulate Parkinson's disease-affected circuitry and attenuate the core motor symptoms of Parkinson's disease in rodent and nonhuman primate animals. The study was published in Cell on Nov. 2. Parkinson's disease, characterized by the loss of midbrain dopaminergic neurons, is one of the most common neurodegenerative diseases in the elderly population, affecting more than 6 million people worldwide. Dopamine ...

Higher risk of breast cancer in women with false positive mammography result

2023-11-02

Women who receive a false positive mammography result are more likely to develop breast cancer over the subsequent 20 years, report researchers from Karolinska Institutet in a study published in JAMA Oncology. The risk is highest for women aged between 60 and 75 and who have low breast density. In global terms, breast cancer is the most common form of cancer among women, and screening is an important tool for catching women with a tumour at the earliest possible stage. In Sweden, all women between ...

PTSD symptoms and cardiovascular and brain health in women

2023-11-02

About The Study: In this study of 274 midlife women, greater posttraumatic stress disorder (PTSD) symptoms were associated with higher carotid atherosclerosis and, among women who were APOEɛ4 carriers, greater brain small vessel disease and poorer cognitive performance. These findings point to the adverse implications of PTSD symptoms for cardiovascular and neurocognitive health among women in midlife, particularly for women who are APOEɛ4 carriers. Authors: Rebecca C. Thurston, Ph.D., of the University of Pittsburgh, is the corresponding author. To access the embargoed ...

Breast cancer incidence after a false-positive mammography result

2023-11-02

About The Study: The findings of this study suggest that the risk of developing breast cancer after a false-positive mammography result differs by individual characteristics and follow-up. These findings can be used to develop individualized risk-based breast cancer screening after a false-positive result. Authors: Xinhe Mao, M.Sc., of the Karolinska Institutet in Stockholm, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamaoncol.2023.4519) Editor’s Note: Please ...

Practicing mindfulness can help people make heart-healthy eating choices

2023-11-02

PROVIDENCE, R.I. [Brown University] — Practicing mindfulness focused on healthy eating can be good for the heart, a new study shows, because it improves self-awareness and helps people stick to a heart-healthy diet. When people who had elevated blood pressure participated in an eight-week mindfulness-based blood pressure reduction program for the study, they significantly improved their scores on measures of self-awareness and adherence to a heart-healthy diet compared to a control group. The results were published in JAMA Network Open. “Participants ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce